Hogwarts Legacy Expands: Sony-Exclusive Content Goes Beyond PlayStation This Summer

Hogwarts Legacy — a Harry Potter-inspired video game from Warner Bros Discovery Inc (NASDAQ: WBD) and Avalanche Software — confirmed that players on non-PlayStation platforms will soon have access to

Hogwarts Legacy — a Harry Potter-inspired video game from Warner Bros Discovery Inc (NASDAQ:WBD) and Avalanche Software — confirmed that players on non-PlayStation platforms will soon have access to Sony-exclusive content.

The announcement, made on social media platform X (formerly Twitter), coincides with the upcoming one-year anniversary of the video game’s launch.

See Also: ‘Hogwarts Legacy’ Touts 22M Copies Sold In 2023: Warner Bros. Discovery Teases Future Projects

The specific release date for the content on platforms like PC, Nintendo Switch, Xbox One, and Xbox Series X | S is not specified, but it is expected to be available sometime in the summer.

The current PlayStation-exclusive content includes the Haunted Hogsmeade quest, providing access to the Hogsmeade Shop and the Shopkeeper cosmetic set upon completion.

Additionally, the post promises more updates and features for Hogwarts Legacy, although the details of these enhancements are not yet revealed.

Hogwarts Legacy achieved significant success, surpassing Call of Duty: Modern Warfare 3 in sales in 2023, with an impressive 22 million units sold.

Despite technical issues, and some enemy variety concerns, the game received positive reviews for its enchanting experience.

Read Next: This Best-Selling Game Outsold Modern Warfare 3 In US — Can You Guess Which One?

Image credits: Miguel Lagoa on Shutterstock.

Total
0
Shares
Related Posts
Read More

Salona Global Executes Binding Agreement to Acquire the Physical Medicine Assets of Mirion Technologies’ Biodex Medical Systems for Up to $8M

Salona Global Medical Device Corporation ("Salona Global," "SGMD," or the "Company") (TSXV:SGMD) has executed a definitive asset purchase agreement (the "Asset Purchase Agreement") to acquire the physical medicine assets (the "Acquired Assets") of Biodex Medical Systems, Inc. ("Biodex").

TSXV:SGMD